Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 373,554 | 357,257 | 375,235 | 394,363 | 477,001 |
| Income taxes - deferred | 3,343 | 22,553 | -22,622 | -30,487 | 46,493 |
| Accounts receivable | 98,937 | -58,385 | 183,528 | -293,141 | 25,678 |
| Accounts payable and accrued liabilities | -108,366 | 310,867 | -84,869 | -105,184 | 63,226 |
| Other Working Capital | 152,904 | 88,495 | 281,863 | -385,024 | 217,219 |
| Other Operating Activity | 481,314 | 20,772 | 41,795 | 582,297 | 2,085 |
| Operating Cash Flow | $1,001,686 | $741,559 | $774,930 | $162,824 | $831,702 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -417,959 | -191,916 | -146,504 | -142,295 | -233,091 |
| Net Acquisitions | 35,258 | 140,402 | -8,174 | 12,682 | 123,120 |
| Purchase Of Investment | -62,077 | -14,041 | 167 | -11,570 | -16,912 |
| Sale Of Investment | 26,548 | 11,550 | 12,457 | 32,942 | 7,689 |
| Investing Cash Flow | $-418,230 | $-54,005 | $-142,054 | $-108,241 | $-119,194 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -53,111 | 65,096 | -87,841 | 91,508 | -100,905 |
| Debt Issued | 500,760 | 7,590 | 1,100,107 | 14,096 | 21,152 |
| Debt Repayment | -161,943 | -676,974 | -465,093 | -184,613 | -758,060 |
| Common Stock Repurchased | -434,166 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -59,929 | -530,965 | -467,950 | -59,779 | -127,372 |
| Financing Cash Flow | $-208,389 | $-1,135,253 | $79,223 | $-138,788 | $-965,185 |
| Exchange Rate Effect | -32,176 | -16,216 | -70,651 | -22,434 | 50,793 |
| Beginning Cash Position | 1,256,222 | 1,720,137 | 1,078,689 | 1,185,328 | 1,387,212 |
| End Cash Position | 1,599,113 | 1,256,222 | 1,720,137 | 1,078,689 | 1,185,328 |
| Net Cash Flow | $375,067 | $-447,699 | $712,099 | $-84,205 | $-252,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,001,686 | 741,559 | 774,930 | 162,824 | 831,702 |
| Capital Expenditure | -423,012 | -192,214 | -154,383 | -145,760 | -240,690 |
| Free Cash Flow | 578,674 | 549,345 | 620,547 | 17,064 | 591,012 |